Skip to content
Wednesday, December 17, 2025
AI blueprint from NAACP prioritizes health equity in model development

AI blueprint from NAACP prioritizes health equity in model development

December 17, 2025December 17, 2025
AI guardrails are essential to protect patient safety

AI guardrails are essential to protect patient safety

December 17, 2025December 17, 2025
Exploring the Fit Between the Outputs of Freely Available Medication Adherence Apps and Users’ Needs: Mixed Methods Study

Exploring the Fit Between the Outputs of Freely Available Medication Adherence Apps and Users’ Needs: Mixed Methods Study

December 17, 2025December 17, 2025
News 12/17/25

News 12/17/25

December 17, 2025December 17, 2025
Mediformatica

Mediformatica

The Digital Health News Aggregator

  • Blog
  • Latest News
    • AI News
  • Videos
  • Podcasts
  • Daily Digest
  • Taxonomy
  • About
    • MediFormatica
    • Hazem El-Oraby
    • Stay “In The Know…”
    • Legacy Website
    • Sitemap

Tag: MBX Capital

Why MBX Capital is Betting $100M on the Link Between Industrial Toxins and Chronic Disease

Why MBX Capital is Betting $100M on the Link Between Industrial Toxins and Chronic Disease

December 16, 2025December 17, 2025HIT Consultant

What You Should Know: 

– MBX Capital has secured over $100M in capital commitments to invest in early-stage biotech and health tech companies, specifically focusing on “deep health” solutions that address diseases linked to environmental…

Continue Reading
Vivodyne Secures $40M Series A to Scale AI-Powered Human Tissue Testing

Vivodyne Secures $40M Series A to Scale AI-Powered Human Tissue Testing

May 30, 2025May 31, 2025HIT Consultant

What You Should Know: 

– Vivodyne, a company pioneering an exclusively human-focused preclinical process, today announced it has raised $40M in new Series A funding led by Khosla Ventures, with participation from new investors Lingotto…

Continue Reading
Persist AI secures $12M Series A Funding, unveiled Cloud Lab platform

Persist AI secures $12M Series A Funding, unveiled Cloud Lab platform

May 22, 2025May 23, 2025MobiHealthNews

Persist AI, an AI-driven robotics platform for the pharmaceutical industry, announced an overscribed $12 million Series A funding round.Spero Ventures led the round with participation from MBX Capital, Shimadzu Future Innovation Fund managed by…

Continue Reading
Persist AI secures $12M Series A funding, unveils Cloud Lab platform

Persist AI secures $12M Series A funding, unveils Cloud Lab platform

May 22, 2025May 23, 2025MobiHealthNews

Persist AI, an AI-driven robotics platform for the pharmaceutical industry, announced an overscribed $12 million Series A funding round.Spero Ventures led the round, with participation from MBX Capital, Shimadzu Future Innovation Fund managed by…

Continue Reading
Keebler Health Raises $6M to Transform Risk Adjustment with AI-Powered Platform

Keebler Health Raises $6M to Transform Risk Adjustment with AI-Powered Platform

February 18, 2025February 19, 2025HIT Consultant

What You Should Know: 

– Keebler Health, a provider of AI-native risk adjustment solutions for healthcare providers, today announced a $6 million seed funding round led by Freestyle Capital with participation from MBX Capital, New…

Continue Reading
Exclusive: Keebler Health secures $6M for product development

Exclusive: Keebler Health secures $6M for product development

February 18, 2025February 18, 2025MobiHealthNews

AI-enabled risk adjustment platform Keebler Health has raised $6 million in seed funding.Freestyle Capital, MBX Capital, New Stack Ventures, Underdog Labs, Everywhere VC, Ludlow Ventures, Primordial, the Tweener Fund, the Hustle Fund, Deb Liu…

Continue Reading
Vivodyne Secures $38M for AI-Powered Drug Discovery Platform

Vivodyne Secures $38M for AI-Powered Drug Discovery Platform

November 30, 2023November 30, 2023HIT Consultant

Vivodyne started as an idea between Co-Founders Andrei Georgescu (left), now Vivodyne’s CEO, and UPenn Professor Dan Huh (right), now Vivodyne’s CSO, while Andrei performed his Ph.D. graduate studies in Huh’s bioengineering research lab….

Continue Reading
Vivodyne launches with $38M to create lab-grown human organs

Vivodyne launches with $38M to create lab-grown human organs

November 23, 2023November 23, 2023MobiHealthNews

Philadelphia-based AI-enabled biotech company Vivodyne announced it closed a $38 million seed funding round led by Khosla Ventures.CS Ventures, Kairos Ventures, Bison Ventures and MBX Capital also participated in the round. 
WHAT THEY DO
Vivodyne is…

Continue Reading
Forum Launches with $5M for Virtual Peer Support Groups to Help People Navigate Life's Challenges

Forum Launches with $5M for Virtual Peer Support Groups to Help People Navigate Life’s Challenges

November 10, 2023November 10, 2023HIT Consultant

Rajiv Kumar, MD, Co-Founder & CEO (Left) and Lee Pichette Co-Founder, President & COO (Right)

What You Should Know:

– Forum, a peer support group marketplace, has officially launched with $5.3M in funding from a seed…

Continue Reading

FOLLOW US ON SOCIAL MEDIA

Quotes

The vaccine rollout process is a classic case study for successful projects requiring "people, process and technology." In this equation, the technology infrastructure of an electronic health record and network connectivity seem to be sufficient at most health systems and communities to support the cause. As a result, the most crucial elements to enable success is the project leadership and teamwork amongst all segments of the healthcare delivery system (people and process).

Michael Restuccia

Recent Posts

  • AI blueprint from NAACP prioritizes health equity in model development

    AI blueprint from NAACP prioritizes health equity in model development

    December 17, 2025December 17, 2025Comments Off on AI blueprint from NAACP prioritizes health equity in model development
  • AI guardrails are essential to protect patient safety

    AI guardrails are essential to protect patient safety

    December 17, 2025December 17, 2025Comments Off on AI guardrails are essential to protect patient safety
  • Exploring the Fit Between the Outputs of Freely Available Medication Adherence Apps and Users’ Needs: Mixed Methods Study

    Exploring the Fit Between the Outputs of Freely Available Medication Adherence Apps and Users’ Needs: Mixed Methods Study

    December 17, 2025December 17, 2025Comments Off on Exploring the Fit Between the Outputs of Freely Available Medication Adherence Apps and Users’ Needs: Mixed Methods Study
  • News 12/17/25

    News 12/17/25

    December 17, 2025December 17, 2025Comments Off on News 12/17/25
  • Feasibility and Preliminary Effectiveness of a Mobile App–Based Personalized Exercise Program in Older Patients With Chronic Knee Osteoarthritis: Pilot Randomized Controlled Trial

    Feasibility and Preliminary Effectiveness of a Mobile App–Based Personalized Exercise Program in Older Patients With Chronic Knee Osteoarthritis: Pilot Randomized Controlled Trial

    December 17, 2025December 17, 2025Comments Off on Feasibility and Preliminary Effectiveness of a Mobile App–Based Personalized Exercise Program in Older Patients With Chronic Knee Osteoarthritis: Pilot Randomized Controlled Trial
  • A New Era of Visualization in Operating Rooms Requires Expanded Roles

    A New Era of Visualization in Operating Rooms Requires Expanded Roles

    December 17, 2025December 17, 2025Comments Off on A New Era of Visualization in Operating Rooms Requires Expanded Roles
  • Healthcare leaders reveal 2025’s biggest surprises, part two

    Healthcare leaders reveal 2025’s biggest surprises, part two

    December 16, 2025December 17, 2025Comments Off on Healthcare leaders reveal 2025’s biggest surprises, part two
  • Healthcare leaders reveal 2025’s biggest surprises, Part 2

    Healthcare leaders reveal 2025’s biggest surprises, Part 2

    December 16, 2025December 17, 2025Comments Off on Healthcare leaders reveal 2025’s biggest surprises, Part 2
  • Good news and bad news for RPM in 2026

    Good news and bad news for RPM in 2026

    December 16, 2025December 17, 2025Comments Off on Good news and bad news for RPM in 2026
  • WellSky and uMed expand home-based clinical trial access nationwide

    WellSky and uMed expand home-based clinical trial access nationwide

    December 16, 2025December 17, 2025Comments Off on WellSky and uMed expand home-based clinical trial access nationwide

Tags

ABOUT (2489) Access (2131) AI (6985) AI Group (4579) Artificial Intelligence (3237) Clinical (4807) Daily (1856) data (6273) digital (7507) digital health (7016) EHR (1661) funding (1862) Health (15465) Healthcare (13491) Healthcare IT (5202) Healthcare IT Today (2488) health IT (4277) health tech (1857) HIT (5206) HIT Consultant (4519) Hospital (3074) Hospitals (2316) innovation (1931) intelligence (2739) IT (12535) Management (2699) medcity (1577) Medical (4457) Medicine (2525) network (1701) News (8302) NHS (1814) OR (2067) partnership (1727) Patients (5574) platform (2907) Provider (2247) providers (2429) research (2765) risk (1649) software (1778) study (1661) Technology (5591) THIS (7419) WHO (2144)

MediFormatica

Mediformatica collects and shares the latest news and articles related to Digital Health. MediFormatica also has its own original posts. It's like a one-stop-shop to stay up to date with everything related to Digital Health.

News Aggregator

  • Latest News
  • Daily Reads
  • Frequent Updates
  • Podcasts
  • Videos
  • Daily Digest

Follow us on Social Media

MediFormatica | Theme: News Vibrant by CodeVibrant.
Home
Latest News
In The Know
Search
More
We noticed you've been enjoying MediFormatica's content. Would you like to get notifications on the latest Health Tech news? OK No thanks

Cookie Policy - Terms and Conditions - Privacy Policy